This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Sino Biological
product type :
antibody
product name :
CCN3 / NOV Antibody, Rabbit PAb
catalog :
10264-RP01
quantity :
400µL
price :
219 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
product information
Note :
Online
Catalog Number :
10264-RP01
Product Name :
CCN3 / NOV Antibody, Rabbit PAb
Product Type :
Antibody
Host Species :
Rabbit
Clonality :
Polyclonal
Isotype :
IgG
Size :
400µL
List Price :
219 USD
Product Description :
Produced in rabbits immunized with purified, recombinant full length of human NOV / CCN3 (rh NOV; Catalog#10264-H08B; NP_002505.1; Met 1-Met 357). Total IgG was purified by Protein A affinity chromatography.
SpeciesSummary :
Human
ALTnames :
NOV
Immunogen :
Recombinant Human NOV protein (Catalog#10264-H08B)
Specificity :
Human NOV / CCN3
Purity :
protein A
Buffer :
0.2 μm filtered solution in PBS
Application Summary :
ELISA
Storage :
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
company information
Sino Biological
Building 9, No.18 Kechuang 10th St, BDA, Beijing, 100176
marketing@sinobiological.com
https://www.sinobiological.com
86 400-890-9989
headquarters: China
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.